Korean Daewoong Pharmaceutical Opens R&D Center in India
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's Daewoong Pharmaceutical opened a new research and development center Jan. 20 in the southern India city of Hyderabad as it tries to pave the way for the development of what it called "different generics" and new brand products for the U.S. and European markets